Abstract
Eosinophilic otitis media is an intractable middle ear disease with gelatinous mucoid fluid containing eosinophils associated with bronchial asthma and nasal allergy that sometimes induces deterioration of sensorineural hearing loss. Here, we report a case of eosinophilic otitis media in a 50-year-old woman who received a Nucleus 22 multi-channel cochlear implant in the right ear at the age of 42 years. She had received treatment for bronchial asthma, chronic sinusitis with nasal allergy and otitis media with effusion since the age of 30 years and had noted bilateral sudden deafness and vertigo at the age of 35 years. Preoperative CT and MRI showed cochlear ossification in the left ear, in which mastoidectomy was performed as treatment of eosinophilic otitis media. Long-term follow-up revealed that cochlear implant is indicated for deafness induced by eosinophilic otitis media, and an early decision for cochlear implant surgery is necessary. Steroid administration was remarkably useful in controlling eosinophilic otitis media in patients with bronchial asthma and chronic sinusitis with nasal allergy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cunningham CD, Slattery WH, Luxford WM (2004) Postoperative infection in cochlear implant patients. Otolaryngol Head Neck Surg 131:109–114
Derlacki EL (1952) Aural manifestration of allergy. Am Otol 6:178–179
Fayad JN, Tabaee A, Micheletto JN, Parisier SC (2003) Cochlear implantation in children with otitis media. Laryngoscope 113:1224–1227
Hehar SS, Nikilopoulos TP, Gibbin KP, O’Donoghue GM (2002) Surgery and functional outcomes in deaf children receiving cochlear implants before age 2 years. Arch Otolaryngol Head Neck Surg 128:11–14
Hurst DS (1996) Association of otitis media with effusion and allergy as demonstrated by intradermal skin testing and eosinophil cationic protein levels in both middle ear efuusion and mucosal biopsies. Laryngoscope 106:1128–1137
Iino Y, Nagamine H, Yabe T, Matsutani S (2001) Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma. Clin Exp Allergy 31:1135–1143
Matsutani S, Kobayashi T, Takasaka T (1995) Eosinophilic otitis media. Otolaryngol Head Neck Surg Tokyo 67:712–713
Nagamine H, Iino Y, Kojima C, Miyazawa T, Iida T (2002) Clinical characteristics of so-called eosinophilic otitis media. Auris Nasus Larynx 29:19–28
Pasanisi E, Vincenti V, Bacciu A, Guida M, Berghenti T, Barbot A, Zini C, Bacciu S (2002) Multichannel cochlear implantation in radical mastoidectomy cavities. Otolaryngol Head Neck Surg 127:432–436
Shambaugh GE (1967) Surgery of the ear, 2nd edn. WB Saunders Co, Philadelphia, pp 210–211, 222, 255–256, 272
Suzuki H, Matsutani S, Kawase T, Iino Y, Kawauchi H, Gyo K, Kurono Y, Shinkawa H, Takahashi S, Fukuda S, Moriyama H, Yamashita T, Kobayashi T (2004) Epidemiologic surveillance of “eosinophilic otitis media” in Japan. Otol Jpn 14:112–117
Tomioka S, Yuasa R, Iino Y (1993) Intractable otitis media in cases with bronchial asthma. In: Mogi G, Honjo I, Ishii T, Takasaka T (eds) Recent advances in otitis media. Proceedings of the Second Extraordinary International Symposium. Kugler, Amsterdam New York, pp 183–186
Acknowledgements
This work was supported by the Acute Profound Deafness Research Committee of the Ministry of Health, Labor and Welfare, Tokyo, Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iwasaki, S., Nagura, M. & Mizuta, K. Cochlear implantation in a patient with eosinophilic otitis media. Eur Arch Otorhinolaryngol 263, 365–369 (2006). https://doi.org/10.1007/s00405-005-1006-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-005-1006-2